Analyst Price Target Update on Wright Medical Group (NASDAQ:WMGI)

Wright Medical Group (NASDAQ:WMGI): The mean short term price target for Wright Medical Group (NASDAQ:WMGI) has been established at $26.31 per share. The higher price target estimate is at $33 and the lower price target estimate is expected at $22 according to 13 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $3.97

Many analysts have stated their opinion on the company shares. Guggenheim Securities initiates coverage on Wright Medical Group (NASDAQ:WMGI) The current rating of the shares is Buy. The rating by the firm was issued on June 9, 2016. For the current week, the company shares have a recommendation consensus of Buy.

On the companys insider trading activities, The officer (SVP, Process Improvement), of Wright Medical Group N.V., Walker Jennifer S. had unloaded 1,167 shares at $19.34 per share in a transaction on June 2, 2016. The total value of transaction was $22,570. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Wright Medical Group (NASDAQ:WMGI) stock ended Monday session in the red zone in a volatile trading. The stock closed down 0.12 points or 0.63% at $18.8 with 1,449,065 shares getting traded. Post opening the session at $18.91, the shares hit an intraday low of $18.61 and an intraday high of $19.16 and the price was in this range throughout the day. The company has a market cap of $1,931 million and the number of outstanding shares have been calculated to be 102,713,374 shares. The 52-week high of Wright Medical Group (NASDAQ:WMGI) is $26.78 and the 52-week low is $15.02.

Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.